An Australian medicinal cannabis developer is set to base its UK operations in Birmingham's Precision Health Technologies Accelerator (PHTA).
Cannim, founded in 2017, curates products from across a network of manufacturers to develop medical cannabis through R&D.
It will be based in the first building to be completed on the University of Birmingham's Birmingham Health Innovation Campus (BHIC), comprising 130,000 sq ft. Developed by Bruntwood in partnership with the University, BHIC is set to become a world-leading life sciences hub.
The partnership with PHTA will focus on expanding the understanding of the endocannabinoid system, a physiological system that helps maintain balance within the body. Cannim says that Phytocannabinoids (compounds found in the cannabis plant) have shown promise in treating a variety of conditions such as chronic pain, stress, and sleep disorders, by interacting with this system.
Read more at The Business Desk